Evidence map›Paper›PMID 42265656›Full record

ArticleBMC medical informatics and decision making2026

Wave-aware mortality prediction in COVID-19: a multi-stage feature selection and explainable machine-learning framework.

Elaheh Fereidouni, Shadi Shafaghi, Hamidreza Jamaati, Morteza Mohammadzadeh, Mohammad Abiad, Fatemeh Sadat Hosseini-Baharanchi

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elaheh FereidouniDepartment of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Shadi ShafaghiLung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamidreza JamaatiChronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Morteza MohammadzadehDepartment of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Mohammad AbiadCollege of Business Administration, American University of the Middle East, Al 'Uqaylah, Kuwait.
Fatemeh Sadat Hosseini-BaharanchiDepartment of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran. hosseini.mstat@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMortality among hospitalized COVID-19 patients changed markedly across successive epidemic waves as circulating variants shifted, population immunity increased, and health-system pressures fluctuated. These increasingly heterogeneous conditions raise concerns about whether prediction models developed during early phases remain reliable in later epidemic contexts.

objectiveTo develop a wave-aware machine-learning framework that differentiates between stable physiological predictors of mortality and context-dependent predictors whose importance changed across waves.

methodsWe analyzed 732,654 adult hospitalizations from Iran's national COVID-19 registry across Waves 2-5 and the post-Wave-5 period. All preprocessing, feature selection, and model training were conducted independently within each wave to preserve temporal structure and prevent leakage. A three-stage feature-selection approach Elastic Net shrinkage, Random Forest importance ranking, and Variance Inflation Factor filtering identified both stable and time-varying predictors. Model performance for Logistic Regression, Random Forest, and Deep Neural Networks was evaluated on wave-specific held-out test sets, and temporal robustness was assessed through cross-wave validation.

resultsA consistent physiological vulnerability core age, hypoxemia, and major chronic comorbidities was present across all waves. Nonlinear models outperformed Logistic Regression, with Random Forest achieving AUCs up to 0.94 and F1 scores up to 0.68 in within-wave testing. However, early-wave models showed marked degradation when applied to later waves: cross-wave AUC declined moderately (e.g., RF: 0.87 within-wave → 0.80 early→Wave-5), whereas F1 collapsed due to pronounced miscalibration (e.g., RF F1: 0.68 → 0.13 → 0.07). SHAP analyses revealed increasing importance of vaccination-related variables and shifting comorbidity profiles in later waves. Threshold-sweep analyses suggested that the F1-optimal probability threshold varied widely across models and waves, underscoring the impact of temporal drift on threshold-dependent performance.

conclusionsCOVID-19 mortality risk was determined by a stable physiological core overlaid by dynamic, wave-specific factors shaped by changing variants, immunity, and hospital strain. The divergence between preserved discrimination and degraded F1 demonstrates that static prediction models are highly susceptible to temporal drift. Drift-aware approaches such as recalibration, periodic refitting, or adaptive thresholding may be essential to maintain clinical utility in evolving epidemic environments. The wave-aware, feature-selection-guided, explainable ML framework presented here offers a generalizable basis for developing temporally robust prediction tools for COVID-19 and other rapidly evolving infectious diseases.

Indexed as

COVID-19Machine LearningHumansIranPredictive Learning ModelsRandom ForestConcept driftCOVID-19Deep neural networkElastic netExplainable AIFeature selectionIn-hospital mortalityMachine learningRandom forestSHAPTemporal modeling

Identifiers

PMID42265656
PMCPMC13471308

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.